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Summary
Brown adipocytes increase energy production in response to induction of PGC-1α, a dominant regulator of energy metab-
olism. We have found that the orphan nuclear receptor SHP (NR0B2) is a negative regulator of PGC-1α expression in
brown adipocytes. Mice lacking SHP show increased basal expression of PGC-1α, increased energy expenditure, and
resistance to diet-induced obesity. Increased PGC-1α expression in SHP null brown adipose tissue is not due to β-adrener-
gic activation, since it is also observed in primary cultures of SHP−/− brown adipocytes that are not exposed to such
stimuli. In addition, acute inhibition of SHP expression in cultured wild-type brown adipocytes increases basal PGC-1α
expression, and SHP overexpression in SHP null brown adipocytes decreases it. The orphan nuclear receptor ERRγ is
expressed in BAT and its transactivation of the PGC-1α promoter is potently inhibited by SHP. We conclude that SHP
functions as a negative regulator of energy production in BAT.Introduction
Body weight is a direct outcome of the balance of energy input
and output (Lowell and Spiegelman, 2000), and recent ad-
vances have identified a number of factors that regulate the
input side of this equation (Flier, 2004). Of particular impor-
tance is leptin, a satiety hormone produced by adipose tissue
that acts to limit food intake. In the absence of leptin, both
rodents and humans become massively obese. A number of
other peripheral factors, including gut peptides such as CCK
and PYY, have also been implicated in regulation of energy in-
put (Druce et al., 2004). These factors exert many of their ef-
fects on the brain, where additional signals such as α-MSH
and NPY contribute to the overall control of feeding behavior
(Flier, 2004).
Energy output is also regulated. The best-understood mech-
anism for this is adaptive (or facultative) thermogenesis, which
maintains body temperature when ambient temperatures de-
crease, particularly in rodents and other small mammals. This
is primarily a due to increased energy output in skeletal muscle
and brown adipose tissue (BAT). Muscles shiver to produce
energy in response to cold. In BAT, nonshivering thermogene-
sis converts the energy stored in fat directly into heat in a pro-
cess dependent on β-adrenergic stimulation by the sympa-
thetic nervous system (Cannon and Nedergaard, 2004; Lowell
and Spiegelman, 2000).
The transcriptional coactivator PGC-1α is a key regulator of
adaptive thermogenesis in both BAT and skeletal muscle (Le-
one et al., 2005; Lin et al., 2004; Puigserver and Spiegelman,
2003). In BAT, PGC-1α expression is dramatically induced by
adrenergic stimulation in response to cold stress (Puigserver et
al., 1998). This results in increased mitochondrial biogenesis
due to the function of PGC-1α as a coactivator for nuclear res-CELL METABOLISM : OCTOBER 2005 · VOL. 2 · COPYRIGHT © 2005 ELpiratory factor 1 (NRF-1). By acting as a nuclear receptor co-
activator, PGC-1α also increases expression of the mitochon-
drial uncoupling protein UCP1, which creates a proton leak in
mitochondria that dissipates the energy produced by oxidative
metabolism. The loss of adaptive thermogenesis in BAT of
UCP1 deficient mice (Enerback et al., 1997) and also PGC-1α
mice (Leone et al., 2005; Lin et al., 2004) demonstrates the
importance of UCP1 function in this process.
In addition to a direct inductive response to the increased
levels of cAMP that result from stimulation of the β3-adrenergic
receptor, UCP1 expression is regulated by several nuclear re-
ceptors. Thus, a full thermogenic response requires thyroid
hormone, T3, which can be locally produced in brown adipo-
cytes from T4 by the type II deiodinase. Recent results suggest
increased T3 levels induce UCP-1 expression via the TRβ iso-
form, and also stimulate adrenergic responsiveness via the
TRβα1 isoform (Ribeiro et al., 2001). UCP1 expression can also
be induced by the peroxisome proliferator activated receptor
PPARγ and retinoic acid receptors (del Mar Gonzalez-Barroso
et al., 2000; Puigserver et al., 1998).
Another nuclear receptor cofactor expressed in BAT is the
unusual orphan receptor SHP, which interacts with a number
of other nuclear receptors and strongly inhibits their transacti-
vation function (e.g., Borgius et al., 2002; Johansson et al.,
2000; Lee and Moore, 2002; Seol et al., 1996). This inhibition
is a two-step process in which SHP both competes with co-
activators (including PGC-1α [Borgius et al., 2002; Kanaya et
al., 2004]) for binding to activated nuclear receptors and func-
tions directly as a transcriptional repressor (Johansson et al.,
2000; Lee and Moore, 2002; Seol et al., 1996). In the liver, SHP
inhibition of LRH-1 transactivation is a central aspect of a
negative feedback loop that regulates bile acid production
(Kerr et al., 2002; Wang et al., 2002), and recent results indicateSEVIER INC. DOI 10.1016/j.cmet.2005.08.010 227
A R T I C L EFigure 1. Resistance of SHP null mice to diet-
induced obesity
A) Expression of SHP in white and brown adipose
tissue (data not shown) was detected by immuno-
histochemistry with specific SHP antibodies.
B) Body weight of mice fed a high-fat diet for 12
weeks. The weight gain of the SHP null mice was
lower than that of the wild-type mice (p < 0.01; n =
20/group). Values are percentage of weight gain
from the starting body weight, which did not differ
between wild-type and SHP−/− mice, and are ex-
pressed as the mean ± SEM.
C) Weight of epididymal and subcutaneous fat de-
pots at the end of the high-fat diet are shown (n = 15
to 20/group). Values are expressed as the mean ±
SEM. (*, p < 0.01; **, p < 0.001).
D and E) Glucose tolerance and insulin tolerance
tests were performed after 12 weeks of HF diet in
SHP−/− and control littermates. Values of SHP−/−
mice and controls (n = 10/group) are expressed as
the mean ± SEM. (*, p < 0.01; **, p < 0.001).that SHP overexpression increases hepatic lipogenesis and tri-
glyceride accumulation (Boulias et al., 2005).
To examine the potential role of SHP in metabolic regulatory
pathways associated with obesity, SHP null mice were chal-
lenged with a high-fat diet. In contrast to expectations based
on the association of SHP haploinsufficiency with increased
body weight in humans (Nishigori et al., 2001), SHP−/− mice
were resistant to diet-induced obesity. Characterization of
these mice revealed increased basal PGC-1α expression in
BAT and increased energy production. PGC-1α expression
was also elevated in cultured SHP−/− brown adipocytes re-
moved from potential sympathetic activation, indicating that it
does not require β-adrenergic stimulation, and this was strongly
confirmed by the responses of primary brown adipocytes to
acutely decreased or increased SHP expression. Instead, a di-
rect role for SHP in basal expression of PGC-1α expression
was suggested by its strong inhibition of PGC-1α promoter
transactivation by ERRγ, another orphan receptor expressed in
BAT. These results complement previous studies suggesting
inhibitory effects of SHP on PGC-1α activity (Borgius et al.,2282002; Kanaya et al., 2004) and identify SHP as a novel negative
regulator of energy production.
Results
Loss of SHP protects against diet-induced obesity
The initial characterization of SHP null mice confirmed the pre-
dicted role of this orphan in negative feedback regulation of
bile acid production (Kerr et al., 2002; Wang et al., 2002) but
not in other metabolic pathways as anticipated from its inhibi-
tory effects on a number of other nuclear receptors. In particu-
lar, the body weights of SHP−/− and wild-type mice did not
differ significantly on a normal-chow diet, despite the observa-
tions that SHP mRNA is expressed at low levels in white and
brown adipose tissue as verified by RT-PCR analysis (data not
shown) and immunohistochemistry (Figure 1A), and that SHP
haploinsufficiency has been associated with modestly in-
creased weight in Japanese populations (Nishigori et al., 2001).
To further assess this potential association in mice, we chal-
lenged 8- to 9 -week-old wild-type and SHP null mice with a
35% (w/w) high-fat (HF) diet for 12 weeks. The SHP−/− miceCELL METABOLISM : OCTOBER 2005
Negative regulation of energy production by SHPFigure 2. Decreased lipid accumulation in SHP null
mice
A) Decreased white adipocyte cell size in kidney
(KF), epididymal (EF), and subcutaneous (SF) fat in
SHP−/− mice relative to wild-type mice on high-fat
diet. Fat pads were collected, fixed, and subjected
to hematoxylin and eosin (HE) staining (n = 3/group).
A representative image is shown for each fat pad/
genotype (20× magnification).
B) Livers were collected, fixed, and subjected to
hematoxylin and eosin staining (n = 3/group). Re-
presentative images are shown (20× magnification).
Decreased lipid accumulation was confirmed histo-
logically by Oil Red O staining.
C) Decreased hepatic triglyceride (trig.) and choles-
terol (chol.) accumulation in SHP−/− mice on high-
fat diet (n = 10 to 15/group). Values are expressed
as the mean ± SEM. (*, p < 0.01; **, p < 0.001).showed blunted weight gain in response to this dietary chal-
lenge, which was evident after the first 3 weeks of feeding (Fig-
ure 1B). After 12 weeks, the wild-type mice showed 71 ± 22%
weight gain, but the SHP null mice gained only approximately
half as much, 38 ± 14%. The weight gain of the chow-fed wild-
type (25%) and SHP−/− (21%) mice over the same time period
was not significantly different.
The body-weight difference was largely due to a decrease in
adipose tissue. Epididymal and subcutaneous fat mass was
40% and 60% lower in SHP−/− mice than in wild-type, respec-
tively (Figure 1C). However, inguinal (kidney) fat mass was only
slightly decreased (10%) in SHP−/− mice (data not shown).
The leaner SHP−/− mice showed greater insulin sensitivity.
Their plasma glucose levels were 30% lower than those of the
wild-type mice after a 4 hr fast but were similar to wild-type
after overnight fasting. Serum insulin levels were 20% lower in
the chow-fed SHP−/− mice relative to the wild-type mice and
were markedly lower (70%) on the HF diet. We therefore per-
formed glucose and insulin tolerance tests. As expected, the
less obese SHP−/− mice showed relatively normal responses,
while the HF fed wild-type mice showed glucose intolerance
(Figure 1D) and insulin resistance (Figure 1E).CELL METABOLISM : OCTOBER 2005Adipocytes were enlarged in the white fat of the HF fed wild-
type mice but were smaller and more heterogeneous in size in
SHP null mice (Figure 2A), consistent with their better meta-
bolic status. The HF diet also induced fatty liver in the wide
type mice, but the livers of the HF fed SHP−/− animals con-
tained almost no visible lipid droplets (Figure 2B), which was
confirmed by marked differences in Oil Red O staining (data
not shown). Consistent with this, hepatic triglyceride and cho-
lesterol contents were significantly decreased in SHP−/− mice
(Figure 2C). Hepatic free fatty acids were slightly increased,
although the level did not reach statistical difference (data not
shown).
Total serum triglyceride levels were not different in the wild-
type and SHP null mice, indicating that the reduced-fat weight
is not secondary to decreased lipid availability. However, total
serum cholesterol levels were significantly decreased in SHP−/−
mice compared with wild-type littermates (data not shown).
Loss of SHP increases thermogenesis
in brown adipose tissue
Consistent with an approximately 50% decrease in serum lep-
tin, the SHP−/− mice consume somewhat greater amounts of229
A R T I C L Ethe high-fat diet than the wild-type animals (data not shown).
Thus, their resistance to diet induced obesity should be a con-
sequence of increased energy expenditure. This was confirmed
by a variety of both indirect and direct approaches, including
analysis of oxygen consumption, CO2 generation, heat produc-
tion, and body temperature. HF-fed SHP−/− mice showed sig-
nificantly higher O2 consumption than control wild-type litter-
mates over 24 hr (Figure 3A). Heat production (Figure 3A), CO2
generation, and body temperature were also significantly
higher in the HF fed SHP null mice.
Based on these results, more detailed studies on chow-fed
animals revealed a lesser but significant increase in O2 con-
sumption and heat production in the SHP−/− mice relative to
wild-type mice (Figure 3B). This was apparently balanced by a
modestly increased food intake since, as previously described
(Wang et al., 2002), the chow-fed SHP−/− animals did not show
decreased weight.
A simple explanation for the changes in energy balance ob-
served in the SHP null mice is increased thermogenesis in BAT.
Although the basal body temperature of the chow-fed wild-Figure 3. Increased energy expenditure in SHP−/−
mice
A) Increased O2 consumption and heat production
in SHP−/− mice on high-fat diet. Mice were sub-
jected to indirect calorimetry for 24 hr at the end of
the high-fat diet period (Oxymas, Colombus Instru-
ments) (n = 6/group). Values are expressed as the
mean ± SEM. (**, p < 0.001).
B) Increased O2 consumption and heat production
in SHP−/− mice on normal-chow diet. 8–9 week old
wild-type and SHP−/− mice were fed control chow
diet for 12 weeks to match the age of the high-fat
diet group. Mice were subjected to indirect calorim-
etry at the end of feeding (n = 6/group). (*, p < 0.01).
C) Rectal temperatures of chow-fed wild-type (n =
9) and SHP−/− (n = 13) mice were measured under
basal conditions, after an overnight fast, and after 2
hr of refeeding, as indicated (** p < 0.001). Mice
were subjected to indirect calorimetry for 2 hr at the
end of fasting (n = 6/group) and increased O2 con-
sumption was observed in SHP−/− animals. Values
are expressed as the mean ± SEM. (*, p < 0.01).
D) Resistance of SHP−/− mice to decreased body
temperature subsequent to cold exposure. Rectal
temperatures of chow-fed wild-type and SHP−/−
mice were measured before and at increasing times
after exposure to a 4°C environment. (** p < 0.001;
* p < 0.05). SHP expression of wild-type mice was
analyzed at 0 and 6 hr after cold exposure by North-
ern analysis.230type and SHP null mice did not differ, the body temperature of
fasted SHP null mice was significantly elevated relative to wild-
type and their oxygen consumption was increased (Figure 3C).
Increased thermogenesis should counteract the initial de-
crease in body temperature associated with cold exposure,
and the rate of this decrease was lower in chow-fed SHP−/−
mice than in wild-type (Figure 3D). Consistent with a negative
effect of SHP on thermogenesis in the wild-type mice, the in-
duction of BAT energy production in response to 6 hr of cold
exposure was associated with decreased SHP mRNA expres-
sion (Figure 3D).
As expected from the increased basal energy expenditure,
the interscapular BAT of the high-fat fed SHP−/− mice was
darker in color and had less surrounding WAT than that of wild-
type littermates, although BAT weight was not different be-
tween the two genotypes (data not shown). There was an ap-
proximately 50% increase in cell density in SHP null BAT, and
the SHP−/− brown adipocytes were relatively small, with smaller
lipid droplets (Figure 4A). These changes in the SHP−/− BAT are
not secondary consequences of the high-fat diet but are pres-CELL METABOLISM : OCTOBER 2005
Negative regulation of energy production by SHPFigure 4. Alteration of BAT morphology in SHP−/− mice
A) Hematoxylin and eosin (HE) staining images of BAT from adult mice on high-fat diet or 1-day-old neonates. Similar results were observed with BAT of chow-fed
adult mice BAT (data not shown). Cell density was measured by counting equal areas (n = 3/group, 20× magnification).
B) Electron microscopy of SHP−/− BAT relative to wild-type BAT on both chow (left panels) and high-fat diet (right panels). (n = 3/group, mag. × 12,000).ent from birth, since similar differences were observed in neo-
natal SHP−/− mice and their wild-type siblings (Figure 4A).
Electron microscopy demonstrated increased mitochondrial
content in BAT of both chow and HF fed SHP−/− mice (Figure 4B).
Loss of SHP increases thermogenic gene
expression in brown adipocyte
The emergence of PGC-1α as a central regulator of mitochon-
drial content and energy production provides a potential mech-
anism to account for these effects (Puigserver and Spiegelman,
2003), and normalized PGC-1α mRNA expression was 8- and
10-fold higher in SHP null mice than wild-type mice on the HF
and chow diets (Figure 5A). PGC-1α mRNA was also increased
in white adipose tissue (Figure 5B) but not in other potentialCELL METABOLISM : OCTOBER 2005direct or indirect SHP target tissues including liver, heart, and
skeletal muscle (data not shown). Expression of the mitochon-
drial uncoupling protein UCP1 is required for increased energy
production, and UCP1 mRNA expression in BAT was elevated
in the SHP−/− mice on both the chow (2-fold) and HF (2.3-fold)
diets. Western blotting confirmed that UCP1 protein levels
were also increased (Figure 5C). Though modest, this elevation
of UCP1 expression is comparable to that observed in trans-
genic mice expressing a constitutively active PPARδ transgene
(Wang et al., 2003) and mice lacking the coactivator TIF2/SRC2
(Picard et al., 2002), both of which also show increased energy
production and resistance to diet induced obesity.
Under ordinary circumstances, BAT activation is dependent
on thyroid hormone (T ), which is locally produced from circu-231
3
A R T I C L EFigure 5. Alteration of BAT gene expression in SHP−/− mice
A) Expression of genes involved in BAT thermogenesis was examined by North-
ern blotting. BAT RNA was prepared from mice on chow or high-fat diet, and
representative genes are shown. Fold increase of gene expression in SHP−/− BAT
relative to wild-type BAT was determined by densitometry and normalized to
β-actin.
B) Expression of PGC-1α in white fat was analyzed by Northern blotting.
C) Expression of UCP-1 protein in BAT was analyzed by Western blotting.lating T4 by type 2 deiodinase (Silva, 1995). DIO2 mRNA was
also significantly increased in the SHP null BAT, particularly on
the chow diet (Figure 6A). Since β-adrenergic receptor signal-
ing is required for diet-induced thermogenesis and obesity
(Bachman et al., 2002), expression of three β-adrenergic recep-
tor isoforms was also examined, but no differences were ob-
served (data not shown). PPARα expression in BAT was also
modestly increased, especially on the chow diet, suggesting
increased fatty-acid oxidation in the SHP−/− mice. In addition,
hormone sensitive lipase (HSL) expression was increased
about 2-fold (data not shown). Finally, PPARγ expression was
also increased in SHP−/− BAT, particularly on HF diet, which
may correlate with the increased insulin sensitivity of the mice.
These results raise the important question of whether the
increased BAT activity is a direct consequence of the loss of SHP
function in those cells or a secondary effect of the β-adrenergic
stimulatory pathway. To examine their adrenergic responsive-
ness, wild-type and SHP−/− mice were acutely treated with the
specific β3-adrenergic receptor agonist CL-214,613 (CL). We
hypothesized that the effect of an additional stimulus should
be blunted if the SHP−/− BAT were already subject to endoge-232nous adrenergic activation, but no such decrease was ob-
served. Instead, although the SHP−/− mice showed the ex-
pected higher basal levels of heat production, their induction
of heat production, and oxygen consumption in response to
CL-214,613 was greater than that of the wild-type animals (Fig-
ure 6A). Consistent with this, the elevated basal levels of UCP1
protein in the SHP−/− mice, which were comparable to those
of the CL-214,613-treated wild-type BAT, were further in-
creased by adrenergic stimulation (Figure 6B). As in the cold
exposed wild-type mice, the increased energy production in
the CL-214,613-treated wild-type BAT was associated with de-
creased SHP mRNA levels (Figure 6B).
Explanting and culturing the brown adipocytes provides a
more direct test of the cell autonomous nature of the increased
PGC-1α expression in the SHP−/− BAT, since such cells are
completely removed from the potential stimulatory effects of
adrenergic or other pathways. Consistent with the in vivo re-
sponse to CL-214,613 stimulation, SHP−/− primary brown adi-
pocytes were much more sensitive to the additive effect of T3
and the β-adrenergic receptor agonist noradrenalin, as re-
flected by stronger induction of UCP1 mRNA (Figure 6C).
More importantly, the markedly elevated basal expression of
PGC-1α in cultured SHP−/− brown adipocytes provides strong
evidence for a direct inhibitory effect of SHP on PGC-1α gene
expression (Figure 6D). As in the animal studies, UCP1 expres-
sion was elevated in the cultured SHP−/− brown adipocytes in
the absence of any stimulation (Figure 6D). Activation of the
differentiated cells by the combination of cAMP and 9-cis-reti-
noic acid significantly increased PGC-1α expression in the
wild-type cells, but a more limited response was observed in
the SHP null cells, suggesting that the absence of the repres-
sor results in maximal PGC-1α expression. In agreement with
the results with β-adrenergic receptor stimulation, the SHP−/−
cells showed a remarkably robust induction of UCP1 mRNA
levels in response to cAMP and 9-cis-retinoic acid (9-cisRA),
indicating that UCP1 transcription may also be directly inhib-
ited by SHP, which is known to repress RXR transactivation
(Lee et al., 2000).
These results were confirmed using siRNA to acutely de-
crease SHP expression in the cultured wild-type brown adipo-
cytes. As expected, this increased the low basal expression of
both PGC-1α and UCP1, and treatment of the SHP depleted
cells with cAMP and 9-cis-retinoic acid further increased ex-
pression of both the coactivator and its downstream target
(Figure 6E). Finally, a gain-of-function approach was taken to
further confirm the direct repressive effect of SHP on PGC-1α
expression. SHP null primary brown adipocytes were trans-
duced with an SHP expressing adenovirus or control virus. This
strong SHP overexpression decreased PGC-1α expression to
undetectable levels (Figure 6F). Treatment with cAMP and 9-cis-
retinoic acid brought the repressed PGC-1α expression back
to control level. The dramatic elevation of UCP1 expression in
response to cAMP and 9-cis-retinoic acid in GFP infected cells
was also significantly blunted upon overexpression of SHP.
Overall, these results demonstrate that loss of SHP function
increases PGC-1α expression in the absence of any adrenergic
stimuli and SHP overexpression inhibits it. Alterations of SHP
also affect basal and especially stimulated expression of
UCP1, indicating that it may also be a direct target of SHP
negative regulation.CELL METABOLISM : OCTOBER 2005
Negative regulation of energy production by SHPFigure 6. Cell autonomous function of SHP in BAT
A) Increased heat production and O2 consumption
in SHP−/− mice pretreated for one hour with the β3-
adrenergic agonist CL-316243 (CL) and analyzed for
2 subsequent hr.
B) Expression of UCP-1 protein and SHP mRNA
was analyzed in control and CL-316243 treated
wild-type and SHP−/− BAT.
C) Increased sensitivity of UCP1 to additive T3 and
noradrenaline (NA) in SHP−/− primary BAT adipo-
cytes. Undifferentiated wild-type and SHP null pri-
mary BAT adipocytes were serum starved, then
treated with T3 and NA for 24 hr. UCP-1 gene ex-
pression was analyzed by Northern blotting.
D) Upregulation of PGC-1α and UCP1 in SHP−/− pri-
mary BAT adipocytes. Differentiated wild-type and
SHP−/− primary BAT adipocytes were untreated or
treated with cAMP/9-cisRA for 6 hr and 24 hr, re-
spectively, and PGC-1α and UCP1 gene expression
was analyzed by Northern blotting.
E) Knockdown of SHP expression increases PGC-
1α and UCP1 gene expression. Wild-type primary
BAT adipocytes were grown to confluence, then
transfected with SHP siRNA (S) or control GFP
siRNA. Cells were differentiated and treated with or
without cAMP/9-cisRA as in C. PGC-1α and UCP1
gene expression was analyzed by Northern blotting;
SHP expression was analyzed by RT-PCR.
F) Overexpression of SHP decreases PGC-1α and
UCP1 gene expression. SHP−/− primary BAT adipo-
cytes were grown to confluence and then infected
with a SHP-expressing adenovirus (S) or a control
virus expressing GFP (c) for 2 hr at a multiplicity of
infection of 20. Cells were differentiated and treated
with or without cAMP/9-cisRA as in C. PGC-1α,
UCP1, and SHP gene expression was analyzed by
Northern blotting.SHP represses ERRγ transactivation
of the PGC-1α promoter
To explore the potential molecular basis for the inhibition of
PGC-1α expression by SHP, BAT was screened for expression
of potential SHP nuclear receptor targets. The orphan receptor
ERRγ was identified as a candidate and, in transient transfec-
tions, was found to transactivate an approximately 2 kb PGC-
1α promoter construct (Figure 7A). This transactivation was
strongly and dose dependently inhibited by SHP coexpression,
with the highest amount of SHP expression vector decreasing
PGC-1α promoter activity below the basal level observed with-
out ERRγ (Figure 7A).
The PGC-1α promoter includes several potential matches to
ERRγ consensus sites, including two identical nonamers between
−1769 and −1761, and −203 to −195, relative to the transcrip-CELL METABOLISM : OCTOBER 2005tion start site. Electrophoretic mobility shift analysis confirmed
that ERRγ efficiently bound these sites (Figure 7B), while sev-
eral other potential sites showed lower affinity. The functionality
of the proximal −203 to −195 site was confirmed by the strong
transactivation of a smaller −250 PGC-1α promoter construct
by ERRγ and the absence of such a response in an appropriate
mutant derivative (Figure 7C). In contrast, ERRγ responsive-
ness was retained in a mutant −2000 promoter construct lack-
ing the proximal site but retaining the distal −1769 and −1761
element, indicating this upstream site or possibly other ele-
ments contribute to the overall responsiveness of the full pro-
moter. These results predict that SHP should be recruited to
the PGC-1α promoter, and this was confirmed in the mouse
HIB1B brown adipose cell line using chromatin immunoprecipi-
tation with a SHP antibody and primers flanking the proximal233
A R T I C L EFigure 7. SHP represses ERRγ transactivation of the PGC-1 α promoter
A) SHP represses promoter activity of PGC-1α by ERRγ in a dose-dependent
manner. Cells were transiently transfected with a reporter construct containing 2
kb of mPGC-1α promoter fused to luciferase together with an ERRγ expression
vector in the absence or presence of an SHP expression vector. Similar results
were obtained with a series of 5# deletions of the mPGC-1α promoter (6K, 4K,
2K, 0.9K, and 0.25K) and in either Hela cells or in the brown fat-derived cell
line HIB1B.
B) Specific binding of ERRγ to the potential ERRγ binding site located between
−203 to −195 in the proximal mPGC-1α promoter. ERRγ was in vitro translated,
and DNA binding was assayed in buffer containing 32P-labeled probe, together
with competitor oligonucleotides: s (self), mut (mutant self), and ns (nonspecific).
DNA-protein complexes were resolved by electrophoresis in 6% native acrylam-
ide gels and visualized by autoradiography.
C) Mutagenesis of the mPGC-1α promoter. The −203 to −195 ERRγ site was
mutated using PCR-based site-directed mutagenesis. Transient transfections
were performed with indicated PGC-1α promoter Luc constructs together with
ERRγ (100 ng) expression vector in the absence or presence of SHP expression
vector (100 ng). Luciferase activity was measured and normalized against β-galacto-
sidase activity.
D) Chromatin immunoprecipitation. Crosslinked chromatin was precipitated with
anti-SHP, preimmune, or with no antisera, using primers amplifying the proximal
ERRγ binding site or an upstream sequence, as indicated.ERRγ binding site (Figure 7D). No binding was observed to an
upstream flanking fragment. Overall, we conclude that the
PGC-1α promoter can be potently transactivated by ERRγ and
that this response can be reversed by SHP.234Discussion
Much of the recent insight into the molecular basis for mainte-
nance of energy balance has been based on brain pathways
that modulate energy input (Flier, 2004), but energy output is
also a key factor in determining body weight. The best-studied
mechanism for regulation of energy production is adaptive
thermogenesis, which allows rodents and other small mam-
mals to maintain body temperature in cold environments (Can-
non and Nedergaard, 2004; Lowell and Spiegelman, 2000). The
results described here identify SHP as a potential negative reg-
ulator of energy expenditure in BAT.
This contrasts with the reported association of SHP haploin-
sufficiency with increased body weight in Japanese (Nishigori
et al., 2001) and a possible link between decreased SHP activ-
ity and body weight in European populations (Hung et al.,
2003; Mitchell et al., 2003). However, such differences are con-
sistent with several other examples of divergent effects of loss
of nuclear receptor function in humans and rodents. For exam-
ple, heterozygous loss of function of PPARγ in mice (Miles et
al., 2000) increases insulin sensitivity, while humans with a sin-
gle dominant negative allele have severe insulin resistance
(Barroso et al., 1999). Phenotypic discrepancies are also evident
for HNF-4α (Watt et al., 2003; Yamagata et al., 1996), SF-1
(Achermann et al., 1999) and SHP’s closest relative, DAX-1 (Yu
et al., 1998). In many of these cases, including SHP, phenotypic
differences may be due to dominant negative effects of the
human alleles not shared by the murine null alleles. In addition,
the metabolic effects of a particular gene can be modified by
the effects of other genes, and there are obviously myriad vari-
ations between the murine and human backgrounds. The po-
tential importance of such modifier effects is supported by pre-
liminary analysis of mice carrying the SHP−/− allele in a pure
C57/Bl6 background, which show a more limited increase in
BAT PGC-1α expression than that observed in the 129/SvJ ×
C57/Bl6 mixed background animals described here.
Adaptive thermogenesis in BAT allows rodents to slow the
development of obesity when overfed and maintain body tem-
perature in cold environments (Cannon and Nedergaard, 2004;
Lowell and Spiegelman, 2000). Although BAT has generally not
been thought to play a significant role in this process in hu-
mans, it is important for thermoregulation in human neonates
and could be relevant in adults in several circumstances, in-
cluding activation of the β3-adrenergic receptor (Fisher et al.,
1998; van Baak et al., 2002). Consistent with this, overexpres-
sion of PGC-1α in human white adipocytes confers several
brown adipocyte specific features, including UCP-1 expression
and increased fatty-acid oxidation (Tiraby et al., 2003). These
results suggest that increasing PGC-1α expression in human
white adipose tissue, possibly by decreasing SHP activity as
observed in the SHP−/− mice (Figure 5B), could have beneficial
effects on obesity.
The increased PGC-1α expression observed in BAT of both
chow and HF fed SHP null animals is also observed in primary
brown adipocytes. Since these cultured cells are not subject
to β-adrenergic activation, we conclude that the increased
PGC-1α expression must be a cell autonomous consequence
of the loss of SHP function in BAT. SHP is coexpressed in BAT
with the orphan receptor ERRγ, which can potently stimulate
PGC-1α promoter activity. Both the current and previous re-
sults (Sanyal et al., 2002) show that SHP strongly inhibits ERRγCELL METABOLISM : OCTOBER 2005
Negative regulation of energy production by SHPtransactivation. Thus, the loss of this SHP repression likely
contributes to the increased basal BAT PGC-1α expression in
the SHP null BAT. The marked superinduction of UCP1 expres-
sion in SHP−/− primary brown adipocytes in response to cAMP
and 9-cis-retinoic acid suggests that UCP1 may also be a di-
rect target of negative regulation by SHP. Both the previously
reported repression of RXR transactivation by SHP (Lee et al.,
2000) and the increased thermogenesis observed in the SHP
null animals treated with the β3-adrenergic receptor CL-
214,613 are consistent with this possibility.
Loss of SHP does not lead to increased PGC-1α expression
in other potential metabolic target tissues. This may be due to
differential expression of factors that regulate SHP expression,
including ERRγ. Thus, while SHP expression is high in liver
(Seol et al., 1996), where PGC-1α functions in glucose metabo-
lism (Rhee et al., 2003; Yoon et al., 2001), ERRγ expression is
very low (Sanyal et al., 2002). Basal hepatic PGC-1α expres-
sion is apparently not dependent on ERRγ, HNF-4α (Rhee et
al., 2003) or other transcription factors inhibited by SHP such
as LRH-1. The situation is reversed in skeletal muscle, where
ERRγ is expressed at a low level but SHP expression is absent
(Sanyal et al., 2002).
Increases in energy dissipation and resistance to obesity
similar to those described here were observed in mice that
either lack the nuclear receptor coactivator TIF2/SRC2 (Picard
et al., 2002) or express a VP16-PPARδ fusion protein in adipose
tissue (Wang et al., 2003). A specific increase in BAT UCP1 by
a quite different mechanism also confers resistance to obesity
(Zhou et al., 2003). Thus, increased thermogenesis in BAT pre-
sumably contributes to the increased energy output in the three
nuclear receptor/coactivator mouse models, although prelimi-
nary results also indicate a modest increase in spontaneous
motor activity in the SHP null mice and more detailed studies
will be required to characterize the role of BAT and other poten-
tial targets in overall energy balance in these mice. Like the
TIF2/SRC2 knockouts and VP-16/PPARδ transgenics, how-
ever, the SHP null mice showed no alterations in expression of
PGC-1α or other relevant target genes in skeletal muscle, an-
other potential thermogenic tissue. As reported for the TIF2/
SRC2 null mice, the SHP deficient animals also showed no
changes in serum levels of thyroid hormone or other potential
metabolic activators.
Distinct molecular mechanisms that converge on PGC-1α
activity may account for the increased BAT activity in the three
strains. In the case of the SHP−/− mice, we propose that in-
creased expression of PGC-1α and possibly also UCP1 is a
direct consequence of the loss of this negative nuclear recep-
tor cofactor. Since TIF2/SRC2 negatively regulates PGC-1α
function by blocking the potent synergizing effects of its rela-
tive SRC1, the loss of this coactivator also increases PGC-1α
activity (Picard et al., 2002). Although there was no evidence
for increased PGC-1α expression or function in the VP16-PPARδ
transgenics (Wang et al., 2003), PGC-1α is a PPARδ coactiva-
tor and it is reasonable to assume that the heterologous tran-
scriptional activation domain would have similar positive effects
on appropriate target genes. While the obvious differences in the
mechanisms of activation presumably result in significant varia-
tions, it will be interesting to test the prediction that further
characterization of these three mouse models of obesity resis-CELL METABOLISM : OCTOBER 2005tance will reveal more common phenotypes and further in-
sights into energy balance.
Experimental procedures
Mouse studies
SHP−/− mice were previously described (Wang et al., 2002) and were main-
tained on a C57BL6/129sv hybrid background. Age-matched groups of 2- to
3-month-old SHP+/+ and SHP−/− siblings derived from heterozygous inter-
crosses of SHP+/− were used in the experiments. Unless otherwise indi-
cated, mice were housed 5 per cage in temperature controlled (23°C) virus-
free facilities on a 12 hr light/dark cycle (07:00 on–19:00 off) and fed a
standard rodent chow (test diet no. 5001, 4% [w/w] fat, Harlan Teklad Diets)
and water ad libitum. Age- and sex-matched groups of 8- to 9-week-old
wild-type and SHP−/− mice were used in all the experiments. All protocols
for animal use and euthanasia were approved by the Animal Care Commit-
tee at Baylor College of Medicine and were in accordance with National
Institutes of Health guidelines.
Mice on a high-fat diet were fed chow containing 35.9% fat (Harlan Teklad
Diets) for 12 weeks. High-fat chow has a total energy content of 23.4kj/g,
standard diet 12.6kj/g. On the day before sacrifice, mice were fasted over-
night (15 hr), and blood was collected from the orbital plexus after mice
were anaesthetized with avertin. Liver and fat tissues were removed for
histological analysis. Tissues not used for histology were weighed, sec-
tioned, and snap frozen in liquid nitrogen and stored at –80°C until use.
Histology and immunohistochemistry
Liver was fixed in 4% formaldehyde, dehydrated, embedded in paraffin and
sectioned (4 m). Sections were stained with Harris hematoxylin and eosin
(Sigma). For Oil Red O staining, frozen tissue sections were used. Sections
were examined under bright-field microscopy with an Olympus model BX50
photomicroscope.
Brown adipose tissue was isolated from the back of 8-week-old C57BL/
6J wild-type and SHP−/− mice, and paraffin-embedded sections were pre-
pared. For immunostaining, sections were deparaffinized in xylene 10 min,
three times; rehydrated by immersing in a graded alcohol series (100% ×
3, 95% × 3, 85% × 1, 70% × 1, respectively), 5 min for each step, immersed
in running water for 5 min; boiled in preboiled 10 mM sodium citrate (pH
6.0) for 20 min for antigen retrieval; cooled to room temperature for 20 min,
immersed in PBST for 1 min; incubated with 1% H2O2 in methanol for 15
min at room temperature to block endogenous peroxidase, washed with
PBST (5 min × 3), and blocked in 10% normal goat serum (NGS) for 30 min
at room temperature. Slides were incubated with a 1:50 dilution of rabbit
primary antibody against human SHP (LS-A5395, Lifespan) at 4°C over-
night, washed with PBST (5 min × 3), incubated with biotinylated goat anti-
rabbit IgG (Zymed) for 20 min at room temperature, washed with PBST (5
min × 3), incubated in alkaline phosphatase streptavidin (Zymed) for 20 min
at room temperature, washed with PBST (5 min × 3), developed with the
chromagen substate (Zymed) for 10 min, rinsed with distilled water, coun-
terstained with hematoxylin, and finally mounted in GVA mount.
RNA analysis
Total RNA was isolated from different tissues as indicated using Tri-reagent
(Invitrogen) according the manufacturer’s instruction. For Northern blot
analysis, 10 or 20 g of RNA was denatured, electrophoresed, transferred
to nylon membrane, and probed with different cDNA probes. RNA samples
were processed as previously described (Wang et al., 2002). As also de-
scribed (Wang et al., 2002), all cDNA probes used in this study were pre-
pared by RT-PCR using appropriate primers that are available upon request.
Plasma and tissue chemistry
Serum was prepared from whole blood by centrifugation at 1200 × g for 10
min using Microtainer serum separator tubes (Terumo Medical Corp.) and
frozen in aliquots and stored at –20°C. Enzymatic assay kits were used
for the determination of serum nonesterified fatty acids (NEFA C), glucose,
cholesterol, and total triacylglycerol (Sigma). Serum insulin was measured
using radioimmunoassay (Crystal Chem, Inc.).
To extract lipids, 100 mg of liver was homogenized in chloroform:metha-
nol (2:1) and centrifuged. The lower phase containing the lipid was dried
completely under a stream of N and resuspended uniformly in PBS-Triton235
2
A R T I C L EX-100 solution by ultrasonication. Hepatic triacylglycerol, cholesterol, and
free fatty-acid concentrations were determined as for the serum samples.
Glucose tolerance tests (GTT) were performed on animals that had been
fasted overnight for 16 hr, whereas insulin tolerance tests (ITT) were per-
formed on animals fasted for 4 hr in the morning. Animals were injected
with either 2 g/kg body weight of glucose or 0.75 U/kg body weight of
human insulin (Eli Lilly) into the peritoneal cavity. Glucose levels were mea-
sured from blood collected from the tail immediately before and 30, 60, 120
min (for GTT) or 15, 30, 60 min (for ITT) after the injection using one-touch
blood glucose strips (Fastake, Life Scan).
Oxygen consumption
Oxygen consumption was assessed individually in mice fed a regular chow
or a 35% fat diet using a computer-controlled open-circuit indirect calorim-
etry (Oxymas, Colombus Instruments) with an air flow of 0.5 l/min and a RT
of 23°C. After 30 min for adaptation to the metabolic chamber, VO2, VCO2,
and heat production were assessed at 5 min intervals for a 20–24 hr period.
Mice had free access to water under fasting condition during the 12 hr light
and 12 hr night period. Total oxygen consumption represents the mean of
all samples collected during the experiment.
For testing the effect of β-adrenergic activation, mice were introduced
into the calorimetry chamber for 3 hr to collect baseline data, and then were
intraperitoneally injected with the β3-adrenergic receptor-specific agonist
CL-316243 (1 mg/kg body weight). After 1 hr, O2 consumption and heat
production were measured for 2 hr.
Electron microscopy
Brown adipocyte tissues from wild-type and SHP null mice were fixed with
2% glutaraldehyde in PBS overnight at 4°C and then postfixed in 1% os-
mium tetroxide in phosphate buffer 0.1 M (pH 7.4), dehydrated in ethanol,
and embedded in an Epon-Araldite mixture. Thin sections were obtained
with a MT-X ultramicrotome. Electron microscopy image analysis was per-
formed by Dr. Milton Finegold and Jim Barrish in the Gulf Coast Digestive
Disease Center Core Morphology Laboratory at Texas Children’s Hospital
in Texas Medical Center in Houston.
Primary cell culture
Brown adipocyte progenitors were isolated from interscapular BAT of 3-4 wk
old wild-type and SHP null mice by collagenase disaggregation as described
(Cannon and Nedergaard, 2001) with minor modifications and assistance
from Dr. Sheila Collins (Duke University Medical Center, Durham, NC). Pri-
mary cells were grown in DMEM supplemented with 10% FBS, 100U peni-
cillin, 100 g/ml streptomycin, 0.14 g/ml fungizone, 17 M D-pantothenic
acid, 33 M D-biotin, 100 M ascorbic acid and 4 nM insulin. The medium
was changed 1 day after plating and after 3 days cells were cultured in
differentiation medium containing 50 nM insulin, 50 nM T3 and 1 M rosigli-
tazone for 7 days. Differentiated brown adipocyte cultures were used for
ligand treatment. 1 M of 9-cisRA and 1 mM of 8-Br-cAMP were added to
cells for 24 hr or 6 hr, respectively, before the end of culture. For checking
the additive effect of thyroid hormone and β-adrenergic signaling, freshly
isolated brown adipocyte cells were grown in growth medium to conflu-
ence, and were then serum starved for 24 hr. Cells were further cultured in
charcoal stripped serum medium and treated with T3 and noradrenaline
(NA) at the final concentration of 10 nM and 1M, respectively, for 24 hr.
RNA was isolated for Northern blotting. For all primary cultures, cells were
pooled from 4–15 mice for each experiment.
Adenoviral transduction
Recombinant adenovirus vectors for expression of mPGC-1α, mSHP and
the GFP control were prepared as described (Rhee et al., 2003). Viral super-
natants were generated by standard methods at Baylor College of Medicine
BCM virus Core facility with the assistance of Dr. Kazuhiro Oka. SHP−/−
primary brown adipocytes were isolated as described above and cultured
to 70%–80% confluence. They were plated at 2 × 106 per 10 cm dish and
infected the next day with viral supernatant at different multiplicities of in-
fection for 2 hr. Virus containing media were removed and cells were contin-
uously cultured to induce differentiation, then treated with ligands as indi-
cated above.
T236RNA interference
SHP siRNA was generated by using Dicer siRNA generation kit according
to the manufacture’s instruction (Gene Therapy systems, Inc.). Wild-type
primary brown adipocytes were isolated and cultured until 70%–80% con-
fluence. SiRNA for SH was then transfected into the cells according the
manufacture’s instruction (Gene Therapy systems, Inc.). Cells were then in-
duced to differentiate and treated with ligand as indicated above.
Transient transfection and luciferase assays
Hela or H1B1B cells were maintained in Dulbecco’s Modified Eagle’s Me-
dium in the presence of 10% fetal bovine serum. mPGC-1α promoter 6K,
4K, and 2K Luc constructs were as described (Handschin et al., 2003). Two
additional deletion constructs of mPGC-1α promoter 0.9K and 0.25K were
generated using two upstream primers: sense, 5#-GCGGGGTACCGCTTTA
CAAGGAGCAAGGCAAACTGCAG-3# and 5#-GCGGGGTACCCACTGAGG
CAGAGGGCTGCCTTGGAG-3#; and a common antisense primer, 5#-GCG
GCTCGAGATCCACTCTGACACACAGCACACACTCATG-3#. Mutagenesis of
the 0.25K construct was performed with the Exsite PCR-based site directed
mutagenesis (Stratagene), and all mutations were checked by sequencing.
SHP and ERRγ gene expression vectors were obtained from Dr. Yoonkwang
Lee. For luciferase assays, cells were plated in 24-well plates one day be-
fore transfection, and transfections were carried out using calcium phos-
phate. Total DNA in each transfection was adjusted by adding appropriate
amounts of pcDNA3 vector. Approximately 48 hr posttransfection, cells
were harvested, and luciferase activity was measured and normalized
against β-galactosidase activity as an internal control with a Dual-Luciferase
Reporter System (Promega) in a Lumat LB9501 luminometer (Berthold,
Wildbad, Germany). The transfection experiments were carried out indepen-
dently 3 times with similar efficiency and one representative result is shown.
In vitro translation and DNA binding analysis
In vitro translated proteins were prepared by using a coupled transcription
and translation kit (Promega). The efficiency of ERRγ translation was deter-
mined by a reaction containing [35S] methionine, followed by SDS/PAGE
and Western blotting. For protein-DNA interaction, in vitro-translated ERRγ
was incubated with the following 32P-labeled duplex oligonucleotide probe:
wt: 5#-TTGTGCAGCAAGCTTGCACAGGA. Mutant probe: 5#- TTGTGCAGGA
CCTTGCACAGGA was used as competitor. The wild-type and mutant po-
tential ERRγ binding sequences are underlined. The binding reactions con-
tained 30,000 cpm of 32P-labeled DNA and were incubated for 30 min. with
the in vitro translated proteins in 20 mM Hepes (pH 7.9), 75 mM NaCl, 1
mM dithiotreitol, 2 mM MgCl2, 10% (vol/vol) glycerol/0.1 mg of BSA/10 g/
ml salmon sperm DNA. Competitor oligonucleotides were included at a 10-
to 100-fold molar excess as indicated. DNA-protein complexes were re-
solved by electrophoresis in 6% native acrylamide gels and visualized by
autoradiography.
Statistics
Data were analyzed using one-way ANOVA, followed by student’s t test. p <
0.05 was considered significant.
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